Search research articles
Contact Us
Filters
Showing results (1-10 of 34) with videos related to
Page
of 4
Sort By:
Journal of Neural Transmission. Supplementum
|
October 5, 2006
CYP450, genetics and Parkinson's disease: gene x environment interactions hold the key
G D Mellick
Toxicology and Applied Pharmacology
|
July 1, 1999
Structure-hepatic disposition relationships for phenolic compounds
G D Mellick, M S Roberts
Journal of Pharmaceutical Sciences
|
October 1, 1993
Use of a solute-container interaction to determine protein binding: application to long-chain fatty acids
G D Mellick, M S Roberts
European Journal of Neurology
|
February 2, 2011
Caffeine and Parkinson's disease: are we getting our fix on risk-modifying gene-environment interactions?
G D Mellick, O A Ross
The Journal of Pharmacy and Pharmacology
|
July 1, 1996
The disposition of aspirin and salicylic acid in the isolated perfused rat liver: the effect of normal and retrograde flow on availability and mean transit time
G D Mellick, M S Roberts
Neuroscience Letters
|
October 12, 2000
The ubiquitin carboxy-terminal hydrolase-L1 gene S18Y polymorphism does not confer protection against idiopathic Parkinson's disease
G D Mellick, P A Silburn
The Journal of Pharmacy and Pharmacology
|
November 19, 1997
Impulse-response studies on tracer doses of [14C]lignocaine and its multiple metabolites in the perfused rat liver
G D Mellick, M S Roberts
Neurology
|
August 17, 1999
Parkinson's disease, MAOB, and smoking
G D Mellick, S J McCann, D G Le Couter
Pharmaceutical Research
|
April 6, 2000
An isolated in-situ rat head perfusion model for pharmacokinetic studies
K A Foster, G D Mellick, M Weiss, et al.
The Journal of Pharmacy and Pharmacology
|
March 21, 1998
The effect of protein binding on the hepatic first pass of O-acyl salicylate derivatives in the rat
D Y Hung, G D Mellick, B D Whitehead, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 34) with videos related to
Sort By:
Page
of 4
Journal of Neural Transmission. Supplementum
|
October 5, 2006
CYP450, genetics and Parkinson's disease: gene x environment interactions hold the key
G D Mellick
Toxicology and Applied Pharmacology
|
July 1, 1999
Structure-hepatic disposition relationships for phenolic compounds
G D Mellick, M S Roberts
Journal of Pharmaceutical Sciences
|
October 1, 1993
Use of a solute-container interaction to determine protein binding: application to long-chain fatty acids
G D Mellick, M S Roberts
European Journal of Neurology
|
February 2, 2011
Caffeine and Parkinson's disease: are we getting our fix on risk-modifying gene-environment interactions?
G D Mellick, O A Ross
The Journal of Pharmacy and Pharmacology
|
July 1, 1996
The disposition of aspirin and salicylic acid in the isolated perfused rat liver: the effect of normal and retrograde flow on availability and mean transit time
G D Mellick, M S Roberts
Neuroscience Letters
|
October 12, 2000
The ubiquitin carboxy-terminal hydrolase-L1 gene S18Y polymorphism does not confer protection against idiopathic Parkinson's disease
G D Mellick, P A Silburn
The Journal of Pharmacy and Pharmacology
|
November 19, 1997
Impulse-response studies on tracer doses of [14C]lignocaine and its multiple metabolites in the perfused rat liver
G D Mellick, M S Roberts
Neurology
|
August 17, 1999
Parkinson's disease, MAOB, and smoking
G D Mellick, S J McCann, D G Le Couter
Pharmaceutical Research
|
April 6, 2000
An isolated in-situ rat head perfusion model for pharmacokinetic studies
K A Foster, G D Mellick, M Weiss, et al.
The Journal of Pharmacy and Pharmacology
|
March 21, 1998
The effect of protein binding on the hepatic first pass of O-acyl salicylate derivatives in the rat
D Y Hung, G D Mellick, B D Whitehead, et al.
Page
of 4